Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
-
Tight liquidity NBB
Cash and receivables cover 44 % of short-term debt in 2025; threshold 65 %.
-
Figures corrected NBB
Corrected annual account filed for 2025.
-
Board fully replaced NBB
No director from three years ago is still active according to annual account 2025.
-
Busy address KBO
11 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
PHARMACIE BODEN from Seraing, company number BE0874169146, closed financial year 2025 with a result of € 3,671 after tax. For that financial year PHARMACIE BODEN recorded a gross margin of € 87,365 and equity of € -144,935. Compared with financial year 2024, the result moved from € -47,038 to € 3,671. Profitable, and profit is growing. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 4, 2026.
€ -144,935
▲ € 3,671 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 3,671
▲ still € 47,038 loss in 2024
Profit after tax over the fiscal year.
€ 13,341
▼ 78% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € -609,935.
People and assets in 2025
0
▼ 4 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 1,055
▼ 99% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 888
▼ 47% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 366,710
▼ 14% vs 2024
€ 59,827 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.
€ 14,170
▲ 52% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 12,015
▲ 29% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 311,507 | € 252,510 | € 208,957 | € 87,365 | ▼ 58% |
| Profit after taxes | € 24,727 | € -41,335 | € -47,038 | € 3,671 | ▲ € 50,708 |
| Equity | € -60,233 | € -101,568 | € -148,605 | € -144,935 | ▲ € 3,671 |
| Total debts | € 726,563 | € 734,473 | € 667,098 | € 412,212 | ▼ 38% |
| Cash | € 39,745 | € 57,294 | € 61,674 | € 13,341 | ▼ 78% |
| Land & buildings | € 207,016 | € 219,813 | € 200,328 | € 180,843 | ▼ 10% |
| Retained profit | € -525,233 | € -566,568 | € -613,605 | € -609,935 | ▲ € 3,671 |
| Bank debt | € 543,172 | € 484,850 | € 426,031 | € 366,710 | ▼ 14% |
| Balance sheet total | € 666,329 | € 632,905 | € 518,492 | € 267,278 | ▼ 48% |
| Employees (FTE) | 4 | 4 | 4 | 0 | ▼ 4 |
Key figures of PHARMACIE BODEN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMACIE BODEN?
What happened at PHARMACIE BODEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- P4HOLDING BV stepped down as director. NBB
- Corrected annual accounts filed for financial year 2025. filed late Source: NBB ↗
- Philippe Bartsch became a director. NBB
- Laurent Labille became a director. NBB
- P4HOLDING BV became a director. NBB
- New establishment in Liège. KBO
- Start of the company according to the CBE. KBO
In short
From € 24,727 profit in 2022 to € 3,671 profit in 2025.
Best year ever: 2022, with € 24,727 profit.
On average € 52,200 of value added per employee in 2024.
Management
The stake of P4HOLDING comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
PHARMACIE BODENBehind PHARMACIE BODEN are Philippe Bartsch and Laurent Labille. The shares are held by P4HOLDING (100%).
Directors
According to the 2025 annual accounts
since 2024
since 2024
Managing director · represented by Laurent LABILLE, Philippe Bartsch
since 2021 · until 2027
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Rue de la Boverie 379
4100 Seraing
Rue Saint-Gilles 469
4000 Liège
Active since 31 May 2005
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 11 companies are registered at this address.
All companies at this address →LES PHARMACIES DU PEUPLE - Réseau Solidaris
€ 44.8 million revenue · 2025
Centrale de Services à Domicile - Réseau Solidaris
€ 46 million revenue · 2025
PHARMACIE DES FORGES same network
€ 99,692 gross margin · 2025
GROUPEMENT DES PHARMACIES COOPERATIVES DES PROVINCES FRANCOPHONES
€ -2,713 gross margin · 2025
ACTIMED-RESEAU SOLIDARIS
€ 639,776 gross margin · 2025
+6 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0874.169.146
- VAT number
- BE 0874.169.146
- Registered office
- Rue de la Boverie 379, 4100 Seraing
- Names & denominations
- PHARMACIE BODEN
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 31 May 2005
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers